- Flu/RSV/SARS-CoV-2
- RespiV PlexPlus®
- HCoV QuadPlex
Respiratory Research Use Only (RUO) assays are designed to maximise sample throughput and ensure clinically relevant turn around times for critical patient results.
Flu/RSV/SARS-CoV-2 is a research use only (RUO) 1-well multiplex qPCR consisting of 5 readouts. Readout 1 detects Influenza A virus (Flu A); Readout 2 detects Influenza B virus (Flu B); Readout 3 detects Respiratory syncytial viruses (RSV) type A & type B; Readout 4 detects dual targets for SARS-CoV-2 virus; and Readout 5 is an endogenous control.
RespiV PlexPlus® is a 1-well, multiplex qPCR assay that amplifies nucleic acids of the following targets when present: influenza A virus (including H1N1 and H3N2 strains), influenza B virus (Yamagata and Victoria lineages), respiratory syncytial virus (subtypes A and B), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human adenovirus (species B and C)†, human parainfluenza virus (types 1 to 4), human metapneumovirus, rhinovirus (types A, B and C) and enterovirus (types A, B, C and D)
HCoV QuadPlex is a 1-well, multiplex qPCR assay that amplifies nucleic acids of four seasonal coronaviruses: 229E, NL63, OC43 and HKU1; shown in Table 1. This reagent includes an extraction/amplification internal control.
The reagents are compatible with the Applied Biosystems® QuantStudio™ 5 and 7 real-time PCR systems. The HCoV QuadPlex kit is for research use only (RUO) and is not intended for use in diagnostic procedures.
Note: HCoV Quad Mix, 20x provided contains a fluorophore specific for the QuantStudio™ 5 and 7 platforms.